Madden, Lynn M. and Farnum, Scott O. and Bromberg, Daniel J. and Barry, Declan T. and Mazhnaya, Alyona and Fomenko, Tetiana and Meteliuk, Anna and Marcus, Ruthanne and Rozanova, Julia and Poklad, Iurii and Dvoriak, Sergii and Altice, Frederick L. (2022) The development and initial validation of the Russian version of the BASIS-24. ADDICTION SCIENCE & CLINICAL PRACTICE, 17 (1). ISSN 1940-0640, DOI https://doi.org/10.1186/s13722-022-00343-0.
Full text not available from this repository.Abstract
Background: Efficient and linguistically appropriate instruments are needed to assess response to addiction treatment, including severity of addiction/mental health status. This is critical for Russian-speaking persons in Eastern Europe and Central Asia (EECA) where Medications for Opioid Use Disorder (MOUD) remain underscaled to address expanding and intertwined opioid, HIV, HCV and tuberculosis epidemics. We developed and conducted a pilot validation of a Russian version of the 24-item Behavior and Symptom Identification Scale (BASIS-24), an addiction/mental health severity instrument with six subscales, previously validated in English. Methods: Using the Mapi approach, we reviewed, translated, and back-translated the content to Russian, pilot-tested the Russian-version (BASIS-24-R) among new MOUD patients in Ukraine (N=283). For a subset of patients (n =44), test-rest was performed 48 h after admission to reassess reliability of BASIS-24-R. Exploratory principal component analysis (PCA) assessed underlying structure of BASIS-24-R. Results: Cronbach alpha coefficients for overall BASIS-24-R and 5 subscales exceeded 0.65; coefficient for Relationship subscale was 0.42. The Pearson correlation coefficients for overall score and all subscales on the BASIS-24-R exceeded 0.8. Each item loaded onto factors that corresponded with English BASIS-24 subscales >= 0.4 in PCA. Conclusion: Initial version of BASIS-24-R appears statistically valid in Russian. Use of the BASIS-24-R has potential to guide MOUD treatment delivery in the EECA region and help to align addiction treatment with HIV prevention goals in a region where HIV is concentrated in people who inject opioids and where healthcare professionals have not traditionally perceived MOUD as effective treatment, particularly for those with mental health co-morbidities.
| Item Type: | Article |
|---|---|
| Funders: | United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute on Drug Abuse (NIDA) [R01 DA033679], United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute on Aging (NIA) [R21AG072961], United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute on Drug Abuse (NIDA) [R01DA033679] |
| Uncontrolled Keywords: | Medications for Opioid Use Disorder (MOUD); Eastern Europe and Central Asia (EECA); HIV; BASIS-24-R; PWID; Implementation Science; Validation |
| Subjects: | R Medicine > RA Public aspects of medicine |
| Divisions: | Centre of Excellence for Research in AIDS (CERiA) |
| Depositing User: | Ms Koh Ai Peng |
| Date Deposited: | 29 Oct 2024 06:02 |
| Last Modified: | 29 Oct 2024 06:02 |
| URI: | http://eprints.um.edu.my/id/eprint/46154 |
Actions (login required)
 |
View Item |
